EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa.
S GaucherSu M LwinMatthias TiteuxA Abdul-WahabNathalie PirononAraksya IzmiryanSnaigune MiskinyteClarisse GanierS DuchateletJemima E MellerioEmmanuelle BourratJohn A McGrathAlain HovnanianPublished in: The British journal of dermatology (2019)